Rajnikant Patel v. Karnavati America, LLC

99 A.3d 836, 437 N.J. Super. 415
CourtNew Jersey Superior Court Appellate Division
DecidedOctober 9, 2014
DocketA-2737-13
StatusPublished
Cited by9 cases

This text of 99 A.3d 836 (Rajnikant Patel v. Karnavati America, LLC) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rajnikant Patel v. Karnavati America, LLC, 99 A.3d 836, 437 N.J. Super. 415 (N.J. Ct. App. 2014).

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A-2737-13T4

RAJNIKANT PATEL and RASIKA PATEL, his wife, APPROVED FOR PUBLICATION Plaintiffs-Respondents, October 9, 2014 v. APPELLATE DIVISION KARNAVATI AMERICA, LLC, CADILA PHARMACEUTICAL, LTD, SCHNEIDER ELECTRIC, USA, INC.,

Defendants,

and

KARNAVATI ENGINEERING, LTD,

Defendant-Appellant,

GLOBEPHARMA, INC.,

Defendant-Respondent. _______________________________

Argued September 10, 2014 - Decided October 9, 2014

Before Judges Lihotz, Espinosa and Rothstadt.

On appeal from the Superior Court of New Jersey, Law Division, Middlesex County, Docket No. L-8317-10.

Daniel C. Fleming argued the cause for appellant (Wong Fleming, P.C., attorneys; Mr. Fleming and Mark W. Thompson, on the brief).

Brian M. Gerstein argued the cause for respondents Rajnikant and Rasika Patel (Harkavy, Goldman, Goldman & Gerstein, attorneys; Mr. Gerstein, on the brief).

Larry E. Hardcastle, II, argued the cause for respondent GlobePharma, Inc. (Lanciano & Associates, LLC, attorneys; Mr. Hardcastle and Michael W. Hoffman, on the brief).

The opinion of the court was delivered by

LIHOTZ, P.J.A.D.

We examine whether the Law Division properly exercised

personal jurisdiction over defendant Karnavati Engineering, Ltd.

(Karnavati), a corporation located in India.1 Plaintiff

Rajnikant Patel2 alleged the defective design of a RIMEK UNIK-1

tablet press machine (the machine) manufactured in India by

Karnavati caused him to suffer personal injuries while working

on the New Jersey premises of his employer, Neil Laboratories/

Advent Pharmaceuticals (Neil Labs). On our leave granted,

Karnavati appeals from the Law Division's December 19, 2013

order denying its motion to dismiss plaintiff's complaint for

1 The complaint also named Karnavati's corporate affiliates, Karnavati America, LLC (KAL) and Cadila Pharmaceutical, Ltd. (Cadila) as defendants. The motions of KAL and Cadila to dismiss for lack of personal jurisdiction were granted. 2 For ease, we refer to Rajnikant Patel as the plaintiff, understanding his wife Rasika Patel has filed a derivative per quod claim.

2 A-2737-13T4 lack of jurisdiction. R. 4:6-2(b). Karnavati argues the motion

judge's finding of minimum contacts is factually flawed leading

to an erroneous legal conclusion. We agree and reverse.

The recital of the arduous procedural history detailing

plaintiff's efforts to join and serve parties and proceed with

his suit is not necessary to our discussion of whether New

Jersey has jurisdiction over Karnavati. We limit our discussion

to those facts found in the motion record that are relevant to

our analysis.

Plaintiff resides in Middlesex County and is employed by

Neil Labs, working at its facility in East Windsor. Plaintiff

suffered "severe personal injuries" at the facility on November

4, 2008, when a towel he was using to clean the machine while it

was running, caught and pulled his left hand into the machine.

Plaintiff alleges "[t]he safety interlocks [on the machine] were

either bypassed and/or inoperable." Among the claims included

in his complaint are: the machine was "defectively designed,

manufactured, and/or maintained, causing same to fail"; express

and implied warranties were breached; negligence occurred in the

"design, manufacture, sale, distribution, inspection,

maintenance and/or repair" of the machine; and the failure to

warn of the machine's unreasonably dangerous propensities caused

injury.

3 A-2737-13T4 Karnavati moved to dismiss the complaint in lieu of filing

an answer. Jurisdictional discovery was conducted.3

Mukund Modi, Karnavati's Senior Vice President, filed a

certification averring Karnavati, which manufactures tablet

press machines used in the pharmaceutical industry, was

incorporated and operates in India. Although it manufactured

the machine asserted to cause plaintiff's injuries, Karnavati

never shipped its machines to New Jersey. In fact, since its

incorporation, Karnavati only shipped one product to the United

States, when it sent a different device to Maryland, in December

2003. Modi certified Karnavati is not registered to do business

in New Jersey; does not advertise in New Jersey; has never

engaged in any sales in New Jersey; has never solicited business

from or paid taxes to the state; has never attended trade shows

or conferences "for the purposes of displaying its tablet press

machines, in New Jersey or elsewhere in the United States"; and

has never sent its employees to New Jersey for any reason.

Additionally, Karnavati never owned, used, or possessed real or

personal property in New Jersey; owned or controlled any state

bank accounts; or maintained insurance for products liability

conduct in the state.

3 Plaintiff never sought or argued additional discovery was necessary.

4 A-2737-13T4 Karnavati sold the machine in question to GlobePharma, Inc.

(Globe) in 2002. Globe is a closely held corporation, with a

place of business in New Brunswick. Globe "design[s],

manufacture[s], and s[ells] . . . unit-dose samplers for powders

used in pharmaceutical and nutritional supplement

manufacturing[,]" as well as "new and used pharmaceutical and

nutritional supplement machinery such as . . . table-top rotary

tablet press machines."

The purchase order for the subject machine was prepared by

Globe and sent to Karnavati. Globe sought two machines

described as:

Double Rotary Tablet Press[es], Model KEB— 4/35, with 35 stations for IPT, standard B tooling, GMP model with sturdy acrylic guards AC variable speed drive, gravity feed system, manual lubrication system, safety interlocks and the modifications suggested by Neil [Labs], a list of which was already sent to Mr. Nalk.

In the "Terms & Conditions" section of the purchase order, Globe

provided:

A representative from Neil Labs will visit Karnavati for trial running of the machines. A pharmaceutical powder (which will be shipped from Hyderabad to Karnavati) will be run on these machines. Neil Labs may bring their own tooling or they may need tooling from Karnavati. Neil Labs has to be totally satisfied before the machines are accepted. Modifications suggested by Neil Labs are of essence for acceptance of the machines by Neil Labs.

5 A-2737-13T4 The machine was sent by sea, freight on board, to Globe,

which took possession in Mumbai, India. Globe paid for the

machine before it left India.

This was not the first time Globe and Karnavati did

business. In January 1998, Globe and Karnavati executed an

"Exclusive Distribution Agreement," under which Karnavati agreed

to exclusively supply Globe with "pharmaceutical machinery,

especially tablet presses, packaging machinery, and all-purpose

equipment" within the territorial limits of North America, for a

period of two years. Karnavati agreed to provide a "full

warranty for one year for any manufacturing or material defects

towards machines supplied to Globe." Further, the parties

agreed "[i]f specifically required by Globe, [Karnavati] shall

provide training to the personnel appointed by Globe in

installation, operation, and maintenance of the machines" and

provided Karnavati's technicians would assist Globe. Globe

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
99 A.3d 836, 437 N.J. Super. 415, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rajnikant-patel-v-karnavati-america-llc-njsuperctappdiv-2014.